Home
About
Overview
Sharing Data
ORCID
Help
History (3)
Immunotherapy in Head and Neck Cancer.
The Impact of the Tumor Microenvironment on the Effect of IL-1ß Blockade in NSCLC: Biomarker Analyses from CANOPY-1 and CANOPY-N Trials.
The Italian Mauris Phase IIIb Trial of Atezolizumab Plus Carboplatin and Etoposide for Patients With Newly Diagnosed Extensive-Stage Small Cell Lung Cancer: 3-Year End-of-Study Results.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Immunotherapy in Head and Neck Cancer.
Immunotherapy in Head and Neck Cancer. Cancer Treat Res. 2025; 129:119-156.
View in:
PubMed
subject areas
Head and Neck Neoplasms
Humans
Immunotherapy
authors with profiles
Ravi Salgia